Trials / Completed
CompletedNCT00209456
Dopamine Transporter Scintigraphy Imaging (DAT-Imaging) in Patients With Lewy Body Dementia
GEHC Has Decided Not to Provide This Detail But Will Rely on the Brief Title
- Status
- Completed
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 326 (planned)
- Sponsor
- GE Healthcare · Industry
- Sex
- All
- Age
- 55 Years – 90 Years
- Healthy volunteers
- Not accepted
Summary
The study is designed to determine the diagnostic efficacy of the visual assessment of SPECT scans in differentiating between probable dementia with Lewy Bodies (DLB) and non-DLB dementia subjects determined by the clinical diagnosis of an independent expert consensus panel used as the standard of truth.
Detailed description
GEHC had decided notto provide this detail
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | DatSCAN |
Timeline
- Start date
- 2003-11-01
- First posted
- 2005-09-21
- Last updated
- 2007-05-16
Locations
1 site across 1 country: Germany
Source: ClinicalTrials.gov record NCT00209456. Inclusion in this directory is not an endorsement.